Hancai Dan
- Molecular Biology
- Oncology
- Cancer Research
- Pulmonary and Respiratory Medicine
- Nutrition and Dietetics
- Co-authors
- Jipei LiaoZejia YangKevin J. CullenRena G. LapidusBrandon Carter‐CooperXin‐Yuan GuanXinghuan WangGang Wang
- Topics
- Lung Cancer Treatments and Mutations (5 papers)Cancer-related Molecular Pathways (4 papers)PI3K/AKT/mTOR signaling in cancer (4 papers)
- Partner nations
- United StatesChinaHong Kong
In The Last Decade
Hancai Dan
13 papers receiving 182 citations
Peers
Comparison fields: 5 of 53
- Molecular Biology 115
- Oncology 54
- Cancer Research 47
- Pulmonary and Respiratory Medicine 30
- Nutrition and Dietetics 27
Countries citing papers authored by Hancai Dan
This map shows the geographic impact of Hancai Dan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hancai Dan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hancai Dan more than expected).
Fields of papers citing papers by Hancai Dan
This network shows the impact of papers produced by Hancai Dan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hancai Dan. The network helps show where Hancai Dan may publish in the future.
Co-authorship network of co-authors of Hancai Dan
This figure shows the co-authorship network connecting the top 25 collaborators of Hancai Dan. A scholar is included among the top collaborators of Hancai Dan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hancai Dan. Hancai Dan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 5 | |
| 3 | 10 | |
| 4 | 8 | |
| 5 | 4 | |
| 6 | 2 | |
| 7 | 15 | |
| 8 | 11 | |
| 9 | Concurrent inhibition of ErbB family and MEK/ERK kinases to suppress non-small cell lung cancer proliferation. | 5 |
| 10 | 32 | |
| 11 | Inhibition of cisplatin-resistant head and neck squamous cell carcinoma by combination of Afatinib with PD0325901, a MEK inhibitor. | 16 |
| 12 | 13 | |
| 13 | 59 |
About Hancai Dan
Hancai Dan is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 13 papers that have together received 182 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (5 papers), Cancer-related Molecular Pathways (4 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). The work is most often cited by research in Cancer Research (47 citations), Otorhinolaryngology (11 citations) and Sensory Systems (12 citations). Hancai Dan has collaborated with scholars based in United States, China and Hong Kong. Frequent co-authors include Jipei Liao, Zejia Yang, Kevin J. Cullen, Rena G. Lapidus, Brandon Carter‐Cooper, Xin‐Yuan Guan, Xinghuan Wang, Gang Wang, Guofeng Qian and Rui Cao. Their work appears in journals such as British Journal of Cancer, Oncotarget and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.